Dr Reddy’s, RDIF begin Sputnik-V trials in India

This clinical trials will be a multi-centre and randomised controlled study, which will include safety and immunogenicity study and are being conducted by JSS Medical Research.

published on : 2nd December 2020

Centre to provide advisory support for Russian Covid-19 vaccine trial in India

The development comes after the CDSCO approved an adaptive phase 2 and phase 3 trial of Sputnik V in the country, for which Dr. Reddy is the trial and distribution partner in India.

published on : 29th October 2020

Dr Reddys hopes to finish Phase 3 trials of COVID-19 vaccine by March-May

Sputnik V is currently undergoing phase 3 clinical trials in Russia and the proposed number of subjects is 40,000.

published on : 28th October 2020

Dr Reddy's Laboratories isolates all its data centre services following cyber attack

According to the statement, the company has isolated all data centre services as a 'preventive action'.

published on : 23rd October 2020

Dr Reddy's gets DCGI nod to conduct phase 2/3 human trails of Russian COVID vaccine Sputnik V

The Hyderabad-based drug maker said in a press release that this will bea multi-center and randomised controlled study, which willinclude safety and immunogenicity study.

published on : 17th October 2020

Panel recommends granting permission to Dr Reddy's for phase 2 trials of Russian COVID vaccine

The Hyderabad-based pharmaceutical firm had on October 13 reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phase 2 and 3 human clinical trials.

published on : 17th October 2020

DCGI rejects direct phase 3 trial of Sputnik V in India, asks for trial on smaller group first

The development comes less than a month after the Russian government announced its partnership with Dr Reddy’s Laboratories for mass vaccinations by the year-end.

published on : 7th October 2020

Dr Reddy's asked to reapply for phase two, three clinical trials of Russian COVID-19 vaccine

The Hyderabad-based pharmaceutical company had applied to the DCGI late last week, seeking permission to conduct phase-3 human clinical trials of the Russian vaccine.

published on : 6th October 2020

Dr Reddy's seeks DCGI nod for conducting phase-three trial of Russian COVID-19 vaccine

The Indian pharma giant has collaborated with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V as well as its distribution.

published on : 3rd October 2020

Did Arma Lab tamper with COVID-19 tests of 44 Dubai Police staffers from Kerala?

Meanwhile, another Kozhikode-based laboratory — R-Cell Diagnostics & Research Centre —has filed a complaint against Arma Laboratories with the Valanchery police.

published on : 1st October 2020

Business amid pandemic? Salem private labs, hospitals issuing fake COVID-19 positive reports

With Coronavirus spreading its tentacles far and wide, a few private hospitals and laboratories in Salem district are allegedly cashing in on the scare of the people.

published on : 11th September 2020

What saves us from COVID-19 is our immunity index: Dr A Velumani

Scientist and entrepreneur Dr A Velumani started Thyrocare in 1995, using a business model in a focused biochemistry back end laboratory.

published on : 9th September 2020

Dr Reddy's launches Avigan (Favipiravir) for COVID-19 treatment

Dr Reddy's Avigan comes in a complete therapy pack of 122 tablets with a two-year shelf life.

published on : 19th August 2020

Hyd-based AVRA Labs develops new tech to reduce manufacturing cost of Favipiravir

Dr AV Rama Rao, founder of AVRA Pharmaceuticals, said: “The API, if it is imported from China, costs close to $2,000 per kg, which is about Rs 1.25 lakh.

published on : 27th July 2020

Clinical trial of non-invasive ventilator SwasthVayu to start soon: NAL

It added that there was a compelling need for indigenous ventilators to mitigate the acute shortage of ventilators.

published on : 23rd July 2020
1 2 >